Neil Kumar - Feb 16, 2022 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
CEO and President, Director
Signature
/s/ Yi Ching Yau, Attorney-in-Fact
Stock symbol
BBIO
Transactions as of
Feb 16, 2022
Transactions value $
-$27,271
Form type
4
Date filed
2/18/2022, 03:35 PM
Previous filing
Dec 7, 2021
Next filing
Mar 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Options Exercise +7.52K +0.16% 4.73M Feb 16, 2022 Direct F1
transaction BBIO Common Stock Tax liability -$27.3K -3.09K -0.07% $8.84 4.73M Feb 16, 2022 Direct F2
holding BBIO Common Stock 1.61M Feb 16, 2022 See Footnote F3
holding BBIO Common Stock 1.2M Feb 16, 2022 See Footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBIO Restricted Stock Units Options Exercise $0 -5.13K -10% $0.00 46.2K Feb 16, 2022 Common Stock 5.13K Direct F1, F5
transaction BBIO Restricted Stock Units Options Exercise $0 -2.39K -7.69% $0.00 28.7K Feb 16, 2022 Common Stock 2.39K Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 7,524 shares of Common Stock underlying the Reporting Person's RSUs.
F3 The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F4 The shares are held by Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F5 The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date.
F6 The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date.

Remarks:

Title: Secretary, Treasurer and Chief Financial Officer